Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Eur Rev Med Pharmacol Sci ; 27(23): 11472-11478, 2023 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-38095395

RESUMO

OBJECTIVE: Uric acid to albumin ratio (UAR) reflects inflammatory activity and its predictive value has been shown in various diseases. In this study, we sought to evaluate the value of uric acid to albumin ratio in patients with peripheral arterial disease (PAD). PATIENTS AND METHODS: Two hundred forty-three PAD patients were divided into TransAtlantic Inter-Society Consensus-II (TASC-II) A-B and TASC-II C-D groups, according to their TASC-II classification. Biochemical variables of the patients were recorded, and the UAR of each patient was calculated. RESULTS: Patients who had TASC-II A-B disease were younger than the patients who had TASC-II C-D disease (60.7±8.71 vs. 63.28±8.8 years, p=0.024). Quade ANCOVA results showed that patients with TASC-II C-D disease had higher values of UAR when age was used as a covariate (t=-5.045, p<0.001). Lymphocyte count was significantly lower, and UAR was significantly higher in patients with TASC-II C-D disease (p=0.035 and p<0.001, respectively). UAR and lymphocyte count showed a significant positive correlation and a negative correlation with the TASC-II class of the disease (r=0.403, and r=-0.299, p<0.001 for both). A UAR of 1.54 predicted TASC-II C-D disease with a sensitivity and specificity of 57.9% and 78.8%, respectively. UAR predicted severe PAD with an OR of 3.723. CONCLUSIONS: UAR was a better tool for predicting TASC-II C-D disease compared to uric acid and albumin levels. UAR is an easily calculable parameter that can be used in clinical practice.


Assuntos
Doença Arterial Periférica , Ácido Úrico , Humanos , Resultado do Tratamento , Doença Arterial Periférica/diagnóstico , Albuminas , Sistema de Registros , Artéria Femoral , Estudos Retrospectivos , Grau de Desobstrução Vascular , Stents
2.
Eur Rev Med Pharmacol Sci ; 20(6): 1155-60, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27049271

RESUMO

OBJECTIVE: Cardiac X syndrome is defined in patients with normal coronary angiogram who has typical chest pain and objective myocardial ischemia evidence. Recent studies have evaluated the association between vitamin D deficiency (vit D def) and cardiovascular diseases. Our aim of this study was to compare serum vit D levels in patients with syndrome X and controls. PATIENTS AND METHODS: We included 66 patients (49 women, 17 men) with syndrome X and 47 (30 women, 17 men) healthy controls. All of the patients' demographic features, laboratory analysis and medications are recorded. Vit D is measured quantitatively by paramagnetic particle chemiluminescence method. RESULTS: Mean age of the syndrome X group was higher than controls (56 ± 9.2 vs. 49 ± 9.6 years p < 0.001). Body mass index was higher in the patient group than controls (31.2 ± 5.6 vs. 29.1 ± 4.7 kg/m2 p: 0.011). Vit D levels were significantly lower in the syndrome X group than controls (6 ± 5.2 vs. 11.9 ± 7 ng/ml, p < 0.001). Parathormone levels were significantly higher in the syndrome X group than the control group (38.3 ± 23.4 vs. 28 ± 17.2 pg/ml, p: 0.014). hsCRP levels were higher in the syndrome X group than controls (3.1 ± 5.4 vs. 1.8 ± 2.4 mg/L, p: 0.042). CONCLUSIONS: Our study demonstrated significantly lower vit D levels in patients with CSX. This finding is correlated with previous studies showing an inverse correlation with lower serum vit D levels and different types of cardiovascular diseases. Vit D def may be a risk factor for syndrome X. Vit D def related increased inflammation may lead to the development of endothelial dysfunction and microvascular angina.


Assuntos
Angina Microvascular/metabolismo , Deficiência de Vitamina D/sangue , Vitamina D/sangue , Estudos Transversais , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Fatores de Risco
3.
Artigo em Inglês | MEDLINE | ID: mdl-23366867

RESUMO

Heart sound localization in chest sound is an essential part for many heart sound cancellation algorithms. The main difficulty for heart sound localization methods is the precise determination of the onset and offset boundaries of the heart sound segment. This paper presents a novel method to estimate lower and upper bounds for the onset and offset of the heart sound segment, which can be used as anchor points for more precise estimation. For this purpose, first chest sound is divided into frames and then entropy and smoothed entropy features of these frames are extracted, and used in the Convex-hull algorithm to estimate the upper and lower bounds for heart sound boundaries. The Convex-hull algorithm constructs a special type of envelope function for entropy features and if the maximal difference between the envelope function and the entropy is larger than a certain threshold, this point is considered as a heart sound bound. The results of the proposed method are compared with a baseline method which is a modified version of a well-known heart sound localization method. The results show that the proposed method outperforms the baseline method in terms of accuracy and detection error rate. Also, the experimental results show that smoothing entropy features significantly improves the performance of both baseline and proposed methods.


Assuntos
Auscultação/métodos , Diagnóstico por Computador/métodos , Ruídos Cardíacos/fisiologia , Reconhecimento Automatizado de Padrão/métodos , Sons Respiratórios/diagnóstico , Sons Respiratórios/fisiologia , Espectrografia do Som/métodos , Algoritmos , Humanos , Reprodutibilidade dos Testes , Sensibilidade e Especificidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...